Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-035327
Filing Date
2015-04-21
Accepted
2015-04-21 16:18:21
Documents
1
Period of Report
2015-04-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1553
  Complete submission text file 0001209191-15-035327.txt   2956
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Issuer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2200 PENNSYLVANIA AVENUE NW SUITE 300E WASHINGTON DC 20037
Business Address
Gibbs Thomas Edward (Reporting) CIK: 0001639012 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34186 | Film No.: 15783409